Beyond endpoint lists in rat elevated plus maze pharmacology: Reporting instability and domain-structured interpretation.

Sarapultsev A, Komelkova M

Open source

DOI
10.1016/j.pbb.2026.174241
Published
2026 Oct
Container
Pharmacology, biochemistry, and behavior
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pbb.2026.174241,
  title = {Beyond endpoint lists in rat elevated plus maze pharmacology: Reporting instability and domain-structured interpretation.},
  author = {Sarapultsev A and Komelkova M},
  year = {2026},
  journal = {Pharmacology, biochemistry, and behavior},
  doi = {10.1016/j.pbb.2026.174241},
  url = {https://doi.org/10.1016/j.pbb.2026.174241}
}

RIS

TY  - JOUR
TI  - Beyond endpoint lists in rat elevated plus maze pharmacology: Reporting instability and domain-structured interpretation.
AU  - Sarapultsev A
AU  - Komelkova M
PY  - 2026
JO  - Pharmacology, biochemistry, and behavior
DO  - 10.1016/j.pbb.2026.174241
UR  - https://doi.org/10.1016/j.pbb.2026.174241
ER  - 

APA

A, S., & M, K. (2026). Beyond endpoint lists in rat elevated plus maze pharmacology: Reporting instability and domain-structured interpretation.. Pharmacology, biochemistry, and behavior. https://doi.org/10.1016/j.pbb.2026.174241

Source records